Kirwan James F, Rennie Christina, Evans Jennifer R
Department of Ophthalmology, Queen Alexandra Hospital, Portsmouth, UK.
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD003433. doi: 10.1002/14651858.CD003433.pub3.
The outcome of glaucoma surgery can be affected by the rate at which the surgical wound heals. Beta radiation has been proposed as a rapid and simple treatment to slow down the healing response.
To assess the effectiveness of beta radiation during glaucoma surgery (trabeculectomy).
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2012, Issue 3), MEDLINE (January 1950 to March 2012), EMBASE (January 1980 to March 2012), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). There were no date or language restrictions in the electronic searches for trials. The electronic databases were last searched on 26 March 2012.
We included randomised controlled trials comparing trabeculectomy with beta radiation to trabeculectomy without beta radiation.
We collected data on surgical failure (intraocular pressure > 21 mmHg), intraocular pressure and adverse effects of glaucoma surgery. We pooled data using a fixed-effect model.
We found four trials that randomised 551 people to trabeculectomy with beta irradiation versus trabeculectomy alone. Two trials were in Caucasian people (126 people), one trial in black African people (320 people) and one trial in Chinese people (105 people). People who had trabeculectomy with beta irradiation had a lower risk of surgical failure compared to people who had trabeculectomy alone (pooled risk ratio (RR) 0.23 (95% CI 0.14 to 0.40). Beta irradiation was associated with an increased risk of cataract (RR 2.89, 95% CI 1.39 to 6.0).
AUTHORS' CONCLUSIONS: Trabeculectomy with beta irradiation has a lower risk of surgical failure compared to trabeculectomy alone. A trial of beta irradiation versus anti-metabolite is warranted.
青光眼手术的结果可能会受到手术伤口愈合速度的影响。有人提出用β射线作为一种快速简便的治疗方法来减缓愈合反应。
评估青光眼手术(小梁切除术)期间β射线的有效性。
我们检索了Cochrane中心对照临床试验注册库(CENTRAL)(其中包含Cochrane眼科和视力组试验注册库)(《Cochrane图书馆》2012年第3期)、MEDLINE(1950年1月至2012年3月)、EMBASE(1980年1月至2012年3月)、对照试验元注册库(mRCT)(www.controlled-trials.com)、ClinicalTrials.gov(www.clinicaltrials.gov)以及世界卫生组织国际临床试验注册平台(ICTRP)(www.who.int/ictrp/search/en)。电子检索试验时没有日期或语言限制。电子数据库最后一次检索时间为2012年3月26日。
我们纳入了比较小梁切除术联合β射线与单纯小梁切除术的随机对照试验。
我们收集了手术失败(眼压>21 mmHg)、眼压及青光眼手术不良反应的数据。我们使用固定效应模型汇总数据。
我们发现四项试验,共551人被随机分配接受小梁切除术联合β射线照射或单纯小梁切除术。两项试验针对白种人(126人),一项试验针对非洲黑人(320人),一项试验针对中国人(105人)。与单纯接受小梁切除术的人相比,接受小梁切除术联合β射线照射的人手术失败风险更低(合并风险比(RR)0.23,95%可信区间0.14至0.40)。β射线照射与白内障风险增加相关(RR 2.89,95%可信区间1.39至6.0)。
与单纯小梁切除术相比,小梁切除术联合β射线照射手术失败风险更低。有必要进行β射线照射与抗代谢药物的对比试验。